Article
Single-cell Transcriptome Analysis Uncovers Heterogeneity and Key Regulators in Ibrutinib-resistant Chronic Lymphocytic Leukemia
2021-11-08
Abstract excerpt
<title>Abstract</title> <p><bold>Background</bold>Ibrutinib as a widely used Bruton’s tyrosine kinase inhibitor has shown outstanding value in clinical therapy for chronic lymphocytic leukemia (CLL). However, the bottleneck of ibrutinib resistance has caused widespread concerns, necessitating the exploration of novel targets. <bold>Methods</bold>Single-cell RNA sequencing (scRNA-seq) was used to characterize the...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- be1fd486-e5ea-5fbd-a9bd-c8523e866cfe
- DOI
- 10.21203/rs.3.rs-998561/v1
